Feeds:
Posts
Comments

Search Results for 'double edged'

Tumor Associated Macrophages: The Double-Edged Sword Resolved?

Posted in Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Immuno-Oncology & Genomics, tagged , , , , , , , , , , , , , , , on September 15, 2015| 3 Comments »


Tumor Associated Macrophages: The Double-Edged Sword Resolved? Writer/Curator: Stephen J. Williams, Ph.D. Cell-based immunity is vital for our defense against pathologic insult but recent evidence has shown the role of cell-based immunity, especially macrophages to play an important role in both the development and hindrance of tumor growth, including role in ovarian, hematologic cancers, melanoma, […]

Read Full Post »

Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin

Posted in Biological Networks, Gene Regulation and Evolution, Genome Biology, Interviews with Scientific Leaders, tagged , , , , , on November 9, 2012| 8 Comments »


Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin Curator: Aviva Lev-Ari, PhD. RN As a new edition of The Double Helix hits bookshelves, Boing-Boing‘s Maggie Koerth-Baker takes the opportunity to interview James Watson about his characterization of Rosalind Franklin, who, Koerth-Baker says, “is unfairly maligned in […]

Read Full Post »

SAR-Cov-2 is probably a vasculotropic RNA virus affecting the blood vessels: Endothelial cell infection and endotheliitis in COVID-19

Posted in COVID-19, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, SARS-CoV-2, Treatment Protocols for COVID-19, Virus Infective Acute Respiratory Syndrome: SARS-CoV on June 1, 2020| 1 Comment »


SAR-Cov-2 is probably a vasculotropic RNA virus affecting the blood vessels: Endothelial cell infection and endotheliitis in COVID-19 Reporter: Aviva Lev-Ari, PhD, RN – Bold face and colors are my addition From: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Reply-To: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Date: Tuesday, June 2, 2020 at 8:50 AM To: Aviva Lev-Ari <aviva.lev-ari@comcast.net> Subject: Re: […]

Read Full Post »

Protecting Your Biotech IP and Market Strategy: Notes from Life Sciences Collaborative 2015 Meeting

Posted in Academic Publishing, Affordable Care Act, Bio Instrumentation in Experimental Life Sciences Research, BioSimilars, BioTechnology - Venture Creation, Venture Capital, Commercialization, Conference Coverage with Social Media, Diagnostics and Lab Tests, Drug Delivery Platform Technology, Ecosystems & Industrial Concentration in the Medical Device Sector, FDA, FDA Regulatory Affairs, Global Partnering & Biotech Investment, Health Economics and Outcomes Research, Health Law & Patient Safety, Healthcare costs and reimbursement, HealthCare IT, Healthcare Reform, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Interviews with Scientific Leaders, Investment in Technological Breakthrough, Medical Devices R&D and Inventions, Medical Devices R&D Investment, Medicare and Medicaid, Patents, Personal Health Applications: Tech Innovations serves HealhCare, Pharmaceutical Discovery, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Prescription Drugs Costs, Scientific & Biotech Conferences: Press Coverage, Scientist: Career considerations, Technology Capital Expenses, Uncategorized, Venture Capital, tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on March 11, 2015| Leave a Comment »


  Protecting Your Biotech IP and Market Strategy: Notes from Life Sciences Collaborative 2015 Meeting Achievement Beyond Regulatory Approval – Design for Commercial Success Stephen J. Williams, Ph.D.: Reporter The Mid-Atlantic group Life Sciences Collaborative, a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors whose mission is to […]

Read Full Post »

Diagnostic and Interventional Cardiology (DAIC): 2020 Top 25 Best Performing Articles 

Posted in Frontiers in Cardiology and Cardiovascular Disorders on December 29, 2020| Leave a Comment »


Diagnostic and Interventional Cardiology (DAIC): 2020 Top 25 Best Performing Articles Reporter: Aviva Lev-Ari, PhD, RN   Here are the top 25 best performing articles on the Diagnostic and Interventional Cardiology (DAIC) website from 2020. This is based on the analytics of DAIC’s record 3.3 million pages views in 2020: 1. Kawasaki-like Inflammatory Disease Affects Children […]

Read Full Post »

WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Posted in Cancer and Current Therapeutics on July 30, 2020| 7 Comments »


WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com Curator: Stephen J. Williams, PhD and WordCloud Producers: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD and Aviva Lev-Ari, PhD, RN Introduction (From Cancer Volume 1): Cancer […]

Read Full Post »

Voices of Physicians at Hospitals Caring for Coronavirus Pandemic

Posted in on March 26, 2020|


1/17/2021 Five Countries, Five Experiences of the Pandemic Citizens from around the world share their coronavirus stories. Reporter: Gail S. Thornton, M.A. By Dhruv KhullarJanuary 17, 2021 SOURCE: https://www.newyorker.com/science/medical-dispatch/five-countries-five-experiences-of-the-pandemic?utm_source=nl ### 11/17/2020 Multi-dimensional factors driving the pandemic and how their impact decides any return to the pre- COVID-19 world! Reporter: Gail S. Thornton, M.A. Published on October […]

Read Full Post »

Voices of Global Citizens: Impact of The Coronavirus Pandemic, Gail S. Thornton, M.A. Lead Curator – e–mail Contact: gailsthornton@yahoo.com

Posted in on March 18, 2020|


Voices of Global Citizens: Impact of The Coronavirus Pandemic Gail S. Thornton, M.A.  Lead Curator – e–mail Contact:  gailsthornton@yahoo.com    Voices of Patients Tested Positive to Coronavirus Infections in the US Voices of Nurses and Allied Health Care Professionals in the US in the Coronavirus Pandemic Voices of Physicians at Hospitals Caring for Coronavirus Pandemic Voices of Americans during […]

Read Full Post »

Coronavirus, SARS-CoV-2 Portal

Posted in on March 14, 2020|


CORONAVIRUS, SARS-CoV-2 PORTAL @LPBI   http://lnkd.in/ePwTDxm Launched on 3/14/2020 Eight Pages of LPBI Group’s Coronavirus PORTAL Breakthrough News Corner Development of Medical Counter-measures for 2019-nCoV, CoVid19, Coronavirus An Epidemiological Approach Community Impact Economic Impact of The Coronavirus Pandemic Voices of Global Citizens: Impact of The Coronavirus Pandemic Diagnosis of Coronavirus Infection by Medical Imaging and Cardiovascular […]

Read Full Post »

Economic Potential of a Drug Invention (Prof. Zelig Eshhar, Weitzman Institute, registered the patent) versus a Cancer Drug in Clinical Trials: CAR-T as a Case in Point, developed by Kite Pharma, under Arie Belldegrun, CEO, acquired by Gilead for $11.9 billion, 8/2017.

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, CANCER BIOLOGY & Innovations in Cancer Therapy, CAR-T, Immune Engineering, Immuno-Oncology & Genomics, Immunotherapy, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Interviews with Scientific Leaders, Patent Law in Biotech, Venture Capital on October 4, 2017| Leave a Comment »


Economic Potential of a Drug Invention (Prof. Zelig Eshhar, Weitzman Institute, registered the patent) versus a Cancer Drug in Clinical Trials: CAR-T as a Case in Point, developed by Kite Pharma, under Arie Belldegrun, CEO, acquired by Gilead for $11.9 billion, 8/2017. Curator: Aviva Lev-Ari, PhD, RN   UPDATED on 2/21/2021 The Announcement of the […]

Read Full Post »

Next »